Charles River Laboratories | CRL - EPS Earnings Per Share


Charles River Laboratories reported $2.06 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 3.05 2.43 Nov/11
FY2026Q2 Jun/2026 2.74 3.12 Aug/05
FY2026Q1 Mar/2026 2.06 1.93 2.34 May/07
FY2025Q4 Dec/2025 2.39 2.35 2.66 Feb/18
FY2025Q3 Sep/2025 2.43 2.34 2.59 Nov/05




Eps Change Date
Agilent USD 1.43 0.11 Mar/2026
Align Technology USD 2.64 0.06 Jun/2026
Bio-Rad Laboratories USD 1.89 0.62 Mar/2026
Bruker USD 0.31 0.28 Mar/2026
Cardinal Health USD 3.17 0.54 Mar/2026
Charles River Laboratories USD 2.06 0.33 Mar/2026
Cigna USD 7.78 0.01 Jun/2026
Concord Medical Services Hldg CNY -0.33 0.12 Dec/2025
CVS Health USD 2.57 1.48 Mar/2026
Danaher USD 1.94 0.12 Jun/2026
Dentsply International USD 0.27 0.2 Mar/2026
Elevance Health USD 7.45 5.13 Jun/2026
Humana USD 7.61 2.7 Jun/2026
Illumina USD 1.31 0.16 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Intrexon USD -0.1 0.03 Jun/2024
IQVIA Holdings USD 3.15 0.25 Jun/2026
Laboratory Of America USD 4.99 0.74 Jun/2026
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
McKesson USD 11.69 2.35 Mar/2026
Merck EUR 2.11 0.23 Mar/2026
Mettler Toledo International USD 11.46 2.55 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Quest Diagnostics USD 3.12 0.62 Jun/2026
Revvity USD 1.41 0.35 Jun/2026
Thermo Fisher Scientific USD 6.03 0.59 Jun/2026
United Therapeutics USD 5.82 1.88 Mar/2026
UnitedHealth USD 6.38 0.85 Jun/2026
Veradigm USD -0.34 0.46 Dec/2022
Waters USD 3.05 0.35 Jun/2026
West Pharmaceutical Services USD 2.37 0.24 Jun/2026